1. Home
  2. AAT vs NBTX Comparison

AAT vs NBTX Comparison

Compare AAT & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Assets Trust Inc.

AAT

American Assets Trust Inc.

HOLD

Current Price

$23.61

Market Cap

1.2B

Sector

Real Estate

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$35.15

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAT
NBTX
Founded
1967
2003
Country
United States
France
Employees
208
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
2010
2018

Fundamental Metrics

Financial Performance
Metric
AAT
NBTX
Price
$23.61
$35.15
Analyst Decision
Sell
Strong Buy
Analyst Count
2
1
Target Price
$19.50
$36.00
AVG Volume (30 Days)
352.0K
60.4K
Earning Date
04-28-2026
03-31-2026
Dividend Yield
6.65%
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$436,204,000.00
N/A
Revenue This Year
$4.33
$58.17
Revenue Next Year
$0.22
N/A
P/E Ratio
$298.25
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.72
$4.29
52 Week High
$23.97
$57.14

Technical Indicators

Market Signals
Indicator
AAT
NBTX
Relative Strength Index (RSI) 74.07 40.76
Support Level $18.23 $29.64
Resistance Level N/A $41.89
Average True Range (ATR) 0.53 2.40
MACD 0.12 -1.45
Stochastic Oscillator 87.95 2.24

Price Performance

Historical Comparison
AAT
NBTX

About AAT American Assets Trust Inc.

American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: